Ashland Inc.（ASH）の財務ASHAshland Inc.

Ashland Inc. (ASH) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Life Sciences, accounting for 36.2% of total sales, equivalent to $180.00M. Other significant revenue streams include Personal Care & Household and Specialty Additives. Understanding this composition is critical for investors evaluating how ASH navigates market cycles within the Diversified Chemicals industry.

Evaluating the bottom line, Ashland Inc. maintains a gross margin of 31.99%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 14.29%, while the net margin is 8.25%. These profitability ratios, combined with a Return on Equity (ROE) of 3.99%, provide a clear picture of how effectively ASH converts its operational activities into shareholder value.

In the context of the broader market, ASH competes directly with industry leaders such as FRPT and COCO. With a market capitalization of $3.38B, it holds a significant position in the sector. When comparing efficiency, ASH's gross margin of 31.99% stands against FRPT's 42.11% and COCO's 48.72%. Such benchmarking helps identify whether Ashland Inc. is trading at a premium or discount relative to its financial performance.

Ashland reported a Q3 net income of $16 million, translating to an EPS of $0.35, a significant recovery from previous losses. The gross margin is currently at 31.99%, showing improvement in profitability. The company also reaffirmed its fiscal 2026 sales guidance of $1.835 billion to $1.870 billion, indicating confidence in future revenue growth.